- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-5922
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Current and future pharmacological therapies for NAFLD/NASH ; day:16 ; month:12 ; year:2017 ; pages:1-15
Journal of gastroenterology ; (16.12.2017), 1-15
- Creator
-
Sumida, Yoshio
- Contributor
-
Yoneda, Masashi
SpringerLink (Online service)
- DOI
-
10.1007/s00535-017-1415-1
- URN
-
urn:nbn:de:1111-201802121284
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sumida, Yoshio
- Yoneda, Masashi
- SpringerLink (Online service)
Other Objects (12)
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Natural History of NAFLD/NASH
The role of the microbiome in NAFLD and NASH
Targeting cell death in NAFLD: mechanisms and targeted therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie
gut microbiome in NAFLD : advancing diagnosis, understanding pathogenesis, and developing novel therapies
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Natural History of NAFLD/NASH
The role of the microbiome in NAFLD and NASH
Targeting cell death in NAFLD: mechanisms and targeted therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie
gut microbiome in NAFLD : advancing diagnosis, understanding pathogenesis, and developing novel therapies
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Natural History of NAFLD/NASH
The role of the microbiome in NAFLD and NASH
Targeting cell death in NAFLD: mechanisms and targeted therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie